Test your knowledge about decision making in the CLL frontline setting
{"name":"Test your knowledge about decision making in the CLL frontline setting", "url":"https://www.poll-maker.com/QJOTJV0CU","txt":"Which of the following Bruton’s tyrosine kinase (BTK) inhibitors have demonstrated the lowest rates of hypertension across key clinical trials in patients with CLL?, When compared with ibrutinib, acalabrutinib demonstrated which of the following: Improved progression-free survival (PFS), Del(17p) is associated with favorable outcomes and less aggressive disease in patients with CLL.","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}